| 429 |
A cholesterol/glucose dysmetabolism initiated Tau-driven AOP toward memory loss (AO) in sporadic Alzheimer's Disease with plausible MIE's plug-ins for environmental neurotoxicants |
Erwin L Roggen |
BY-SA |
None
|
1941: Memory Loss
|
|
|
| 427 |
ACE2 downregulation following SARS-CoV-2 infection triggers dysregulation of RAAS and can lead to heart failure. |
Evangelos-Panagiotis Daskalopoulos |
BY-SA |
1739: Binding to ACE2
|
1535: Heart failure
|
|
|
| 426 |
SARS-CoV-2 spike protein binding to ACE2 receptors expressed on pericytes leads to endothelial cell dysfunction, microvascular injury and myocardial infarction. |
Evangelos-Panagiotis Daskalopoulos |
BY-SA |
1739: Binding to ACE2
|
1934: Myocardial Infarction
|
|
|
| 425 |
Oxidative Stress Leading to Decreased Lung Function via Decreased FOXJ1 |
Karsta Luettich |
BY-SA |
1392: Increase, Oxidative Stress
|
1250: Decrease, Lung function
|
|
|
| 424 |
Oxidative stress Leading to Decreased Lung Function via CFTR dysfunction |
Karsta Luettich |
BY-SA |
1392: Increase, Oxidative Stress
|
1250: Decrease, Lung function
|
|
|
| 423 |
Toxicological mechanisms of hepatocyte apoptosis through the PARP1 dependent cell death pathway |
Fei Li |
BY-SA |
2 MIEs
|
1817: Apoptotic cell death
|
|
|
| 421 |
PPARG activation leading to intrahepatic cholestasis |
Yuan Jin |
BY-SA |
None
|
None
|
|
|
| 420 |
Aryl hydrocarbon receptor activation leading to lung cancer through sustained NRF2 toxicity pathway |
Dianke Yu |
BY-SA |
18: Activation, AhR
|
None
|
|
|
| 450 |
Inhibition of AChE and activation of CYP2E1 leading to sensory axonal peripheral neuropathy and mortality |
SAROJ AMAR |
BY-SA |
12: Acetylcholinesterase (AchE) Inhibition
|
2 AOs
|
|
|
| 451 |
Interaction with lung resident cell membrane components leads to lung cancer |
Penny Nymark |
BY-SA |
1495: Substance interaction with the lung resident cell membrane components
|
1670: Lung cancer
|
|
|
| 452 |
Adverse outcome pathway of PM-induced respiratory toxicity |
li qing |
BY-SA |
2007: Non-coding RNA expression profile alteration
|
2008: Chronic obstructive pulmonary disease
|
|
|
| 453 |
Reactive oxygen species and subsequent oxidative stress lead to increased incidence of digestive morbidity and mortality in the general population |
Ruiyang Ding |
BY-SA |
None
|
None
|
|
|
| 454 |
PM2.5-related AOP frameworks on liver diseases |
Zhou Du |
BY-SA |
None
|
None
|
|
|
| 457 |
Succinate dehydrogenase inhibition leading to increased insulin resistance through reduction in circulating thyroxine |
Simon Thomas |
Open for adoption |
2118: Succinate dehydrogenase, inhibited
|
2119: Increase, Insulin resistance
|
|
|
| 458 |
AhR activation in the liver leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals |
Prakash Patel |
Open for adoption |
18: Activation, AhR
|
402: Cognitive function, decreased
|
|
|
| 402 |
Thyroid peroxidase (TPO) inhibition leads to periventricular heterotopia formation in the developing rat brain |
Katherine (Katie) O'Shaughnessy |
BY-SA |
279: Thyroperoxidase, Inhibition
|
2 AOs
|
|
|
| 403 |
combined unhealthy lifestyle factors leading to metabolic syndrome |
Gillina Bezemer |
BY-SA |
None
|
None
|
|
|
| 404 |
Metabolic Syndrome leading to Toll Like Receptor dysregulation |
Gillina Bezemer |
BY-SA |
None
|
None
|
|
|
| 405 |
Organo-Phosphate Chemicals induced inhibition of AChE leading to impaired cognitive function |
SAROJ AMAR |
BY-SA |
12: Acetylcholinesterase (AchE) Inhibition
|
402: Cognitive function, decreased
|
|
|
| 406 |
SARS-CoV-2 infection leading to hyperinflammation |
Hasmik Yepiskoposyan |
BY-SA |
1739: Binding to ACE2
|
1868: Hyperinflammation
|
|
|
| 407 |
SARS-CoV-2 infection leading to pyroptosis |
Hasmik Yepiskoposyan |
BY-SA |
1739: Binding to ACE2
|
1967: Pyroptosis
|
|
|
| 408 |
Imbalance in redox homeostasis leading to structural damage to tissues |
Fei Li |
BY-SA |
None
|
None
|
|
|
| 409 |
Frustrated phagocytosis leads to malignant mesothelioma |
Penny Nymark |
BY-SA |
1668: Frustrated phagocytosis
|
1090: Increased, mesotheliomas
|
|
|
| 410 |
GSK3beta inactivation leading to increased mortality via defects in developing inner ear |
Vid Modic |
BY-SA |
1647: GSK3beta inactivation
|
2 AOs
|
|
|
| 411 |
Oxidative stress Leading to Decreased Lung Function |
Karsta Luettich |
BY-SA |
1392: Increase, Oxidative Stress
|
1250: Decrease, Lung function
|
|
|